Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Global Infectious Disease Diagnostics Market Driven by Evolving Pathogens and Increasing HAIs

By LabMedica International staff writers
Posted on 01 Sep 2022

Immediate diagnosis of infectious disease is the present need of the time due to evolving pathogens and increasing occurrence rate of hospital-acquired infections. More...

The global COVID-19 pandemic has also boosted the demand for laboratory-based molecular testing capacity and reagents. Companies have been working on developing commercial and in-house assays that can identify COVID-19. Governments across the world have also been emphasizing on rapid diagnosis of infectious disease as a strategic priority. As a result, the global infectious disease diagnostics market is projected to surpass USD 28 billion by 2027.

These are the latest findings of Reports and Data (New York City, NY, USA), a market research and consulting company.

The development of commercial and in-house assays that identify COVID-19 is expected to contribute to the growing demand for molecular microfluidics diagnostics. Technological advancements, development of microfluidic-based solutions by various market players, and the scope for automation of complex sample preparations on microchips and reliability associated with it in detecting pathogens will result in surging demand. This will also boost the demand for respiratory testing. Several industry players have been focusing on developing respiratory tests for COVID-19 that would also be applicable for other respiratory pathogens such as influenza A and B. This will further drive the growth of the global infectious disease diagnostics market.

Based on product type, the consumables segment is expected to witness the highest growth due to rising demand for assays and reagents as a result of the growing demand for IDD tests. The increasing occurrence of infectious diseases such as COVID-19 and a growing geriatric population is resulting in increasing demand for IDD tests. In addition, the COVID-19 pandemic is resulting in the development of various commercial and in-house assays to detect the virus, which will also contribute to the segment’s growth.

Based on technology, the molecular diagnostic technique segment is expected to witness the fastest growth, driven by the increasing demand for polymerase chain reaction (PCR) and isothermal nucleic acid amplification tests. Furthermore, the development of assays using this technology such as molecular assays, the use of which is supported by WHO, will also contribute to the segment’s growth. Based on disease type, the hepatitis segment will continue to hold the largest market share due to the growing adoption of developed technologies for hepatitis B diagnosis and high occurrence of the condition, particularly among individuals below 40 years.

 

 


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.